Jan 25 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2023 Dec 31, 2022 Mar 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.79 3.73 5.20
(+1.6 pct) (+7.5 pct) (+5.6 pct)
Operating 794 mln 699 mln 850 mln
(+13.5 pct) (+5.7 pct) (+3.5 pct)
Recurring 811 mln 722 mln 850 mln
(+12.3 pct) (+7.6 pct) (-0.5 pct)
Net 577 mln 497 mln 570 mln
(+16.0 pct) (+8.7 pct) (+0.3 pct)
EPS 138.01 yen 119.24 yen 136.56 yen
Ann Div 25.00 yen 25.00 yen
-Q2 div NIL NIL
-Q4 div 25.00 yen 25.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T